Nifedipine-induced alterations in serum quinidine concentrations. 1984

J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
May 1993, The Annals of pharmacotherapy,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
January 1983, Clinical pharmacy,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
November 1985, Drug intelligence & clinical pharmacy,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
July 1979, American journal of hospital pharmacy,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
April 1979, Metabolism: clinical and experimental,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
November 1984, The American journal of medicine,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
August 1980, Australian and New Zealand journal of medicine,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
January 1994, Psychosomatics,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
November 1983, Clinical pharmacology and therapeutics,
J A Farringer, and J A Green, and R A O'Rourke, and W A Linn, and W A Clementi
June 1986, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!